FEMY
FEMY
NASDAQ · Health Care

Femasys Inc

$1.40
-0.10 (-6.67%)
Financial Highlights (FY 2026)
Revenue
9.71M
Net Income
-78,893,598
Gross Margin
62.0%
Profit Margin
-812.3%
Rev Growth
+23.8%
D/E Ratio
0.54
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 62.0% 62.0% 40.5% 40.5%
Operating Margin -767.0% -690.3% 15.3% 17.8%
Profit Margin -812.3% -771.7% 10.7% 13.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 9.71M 7.85M 15.13M 13.23M
Gross Profit 6.02M 4.86M 6.13M 5.36M
Operating Income -74,491,135 -54,175,370 2.32M 2.35M
Net Income -78,893,598 -57,377,162 1.62M 1.76M
Gross Margin 62.0% 62.0% 40.5% 40.5%
Operating Margin -767.0% -690.3% 15.3% 17.8%
Profit Margin -812.3% -771.7% 10.7% 13.3%
Rev Growth +23.8% +23.8% -2.3% +23.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 2.02M 2.02M 1.56M 1.37M
Total Equity 3.72M 3.72M 10.41M 9.80M
D/E Ratio 0.54 0.54 0.15 0.14
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -73,043,641 -56,073,906 3.07M 2.96M
Free Cash Flow — — 2.53M 2.28M